PULMONX CORPORATION Operating Lease, Right-of-Use Asset, Amortization Expense
PULMONX CORPORATION (LUNG) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $802.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-04
- PULMONX CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $387.00K, a 51.76% increase year-over-year.
- PULMONX CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $415.00K, a 15.28% increase year-over-year.
- PULMONX CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $368.00K, a 10.51% increase year-over-year.
- PULMONX CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $465.00K, a 55.00% increase year-over-year.
- PULMONX CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.45M, a 21.48% decline from fiscal 2024.
- PULMONX CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2024 was $1.84M, a 31.35% decline from fiscal 2023.
- PULMONX CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2023 was $2.69M, a 7.53% increase from fiscal 2022.
- PULMONX CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2022 was $2.50M, a 5.85% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $387.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $802.00K 10-Q · filed 2026-08-04 | $1.17M derived: sum of 3 quarters · filed 2026-08-04 | $1.64M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $415.00K 10-Q · filed 2026-05-04 | $783.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.25M derived: sum of 3 quarters · filed 2026-05-04 | $1.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $833.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.09M derived: sum of 3 quarters · filed 2026-08-04 | $1.45M 10-K · filed 2026-03-10 |
| 2025-09-30 | $465.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $720.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.08M 10-Q · filed 2025-11-12 | $1.41M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $255.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $615.00K 10-Q · filed 2026-08-04 | $948.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.25M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $360.00K 10-Q · filed 2026-05-04 | $693.00K derived: sum of 2 quarters · filed 2026-05-04 | $993.00K derived: sum of 3 quarters · filed 2026-05-04 | $1.50M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $633.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.14M derived: sum of 3 quarters · filed 2026-03-10 | $1.84M 10-K · filed 2026-03-10 |
| 2024-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $810.00K derived: sum of 2 quarters · filed 2025-11-12 | $1.51M 10-Q · filed 2025-11-12 | $2.20M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.21M 10-Q · filed 2025-08-01 | $1.90M derived: sum of 3 quarters · filed 2025-08-01 | $2.57M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $701.00K 10-Q · filed 2025-05-02 | $1.39M derived: sum of 2 quarters · filed 2025-05-02 | $2.06M derived: sum of 3 quarters · filed 2025-05-02 | $2.73M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $689.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.36M derived: sum of 2 quarters · filed 2025-02-25 | $2.03M derived: sum of 3 quarters · filed 2025-02-25 | $2.69M 10-K · filed 2025-02-25 |
| 2023-09-30 | $673.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $1.34M derived: sum of 2 quarters · filed 2024-11-01 | $2.00M 10-Q · filed 2024-11-01 | $2.64M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $670.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.32M 10-Q · filed 2024-08-02 | $1.96M derived: sum of 3 quarters · filed 2024-08-02 | $2.60M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $654.00K 10-Q · filed 2024-05-03 | $1.29M derived: sum of 2 quarters · filed 2024-05-03 | $1.93M derived: sum of 3 quarters · filed 2024-05-03 | $2.54M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $639.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.27M derived: sum of 2 quarters · filed 2024-02-27 | $1.88M derived: sum of 3 quarters · filed 2024-02-27 | $2.50M 10-K · filed 2024-02-27 |
| 2022-09-30 | $633.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.25M derived: sum of 2 quarters · filed 2023-11-03 | $1.86M 10-Q · filed 2023-11-03 | $2.45M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $612.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.23M 10-Q · filed 2023-08-04 | $1.82M derived: sum of 3 quarters · filed 2023-08-04 | $2.44M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $614.00K 10-Q · filed 2023-05-08 | $1.21M derived: sum of 2 quarters · filed 2023-05-08 | $1.82M derived: sum of 3 quarters · filed 2023-05-08 | $2.40M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $594.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.21M derived: sum of 2 quarters · filed 2023-03-01 | $1.79M derived: sum of 3 quarters · filed 2023-03-01 | $2.36M 10-K · filed 2023-03-01 |
| 2021-09-30 | $617.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.19M derived: sum of 2 quarters · filed 2022-11-08 | $1.77M 10-Q · filed 2022-11-08 | $2.28M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $577.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.15M 10-Q · filed 2022-08-08 | $1.66M derived: sum of 3 quarters · filed 2022-08-08 | $2.10M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $572.00K 10-Q · filed 2022-05-09 | $1.08M derived: sum of 2 quarters · filed 2022-05-09 | $1.52M derived: sum of 3 quarters · filed 2022-05-09 | $1.83M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $512.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $947.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.25M derived: sum of 3 quarters · filed 2022-03-01 | $1.47M 10-K · filed 2022-03-01 |
| 2020-09-30 | $435.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $742.00K derived: sum of 2 quarters · filed 2021-11-09 | $955.00K 10-Q · filed 2021-11-09 | $1.22M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $307.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $520.00K 10-Q · filed 2021-08-10 | $782.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $213.00K 10-Q · filed 2021-05-12 | $475.00K derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $262.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $836.00K 10-K · filed 2021-03-15 | ||
| 2019-09-30 | $574.00K 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |